Amgen

Últimas notícias

Manchetes no idioma original da fonte.

• Amgen Inc. stock underperforms Friday when compared to competitors (abre em uma nova aba)

  MarketWatch · 2 de out. de 2026

• Ohio Rep. David Taylor Bought Up to $45K Worth of Amgen Stock (abre em uma nova aba)

  Benzinga · 2 de out. de 2026

• Wells Fargo Maintains Amgen(AMGN.US) With Hold Rating, Maintains Target Price $435 (abre em uma nova aba)

  Moomoo · 2 de out. de 2026

• 
  J&J's Innovative Medicine Segment in Q3: Key Growth Drivers to Watch (abre em uma nova aba)

  2 de out. de 2026

• Amgen wins Sjogren's trial as Jefferies raises target for Amgen stock (abre em uma nova aba)

  AD HOC NEWS · 2 de out. de 2026

• 3 Dow Jones Stocks with Exciting Potential (abre em uma nova aba)

  2 de out. de 2026

• Amgen Inc Stock (AMGN) Closed Down by 3.38% on Oct 1: What Investors Need To Know (abre em uma nova aba)

  TradingKey · 2 de out. de 2026

• Amgen Inc (AMGN) Shares Fall 3.4% -- GF Value Says Still Overval (abre em uma nova aba)

  GuruFocus · 1 de out. de 2026

• Amgen (AMGN) Stock Dips While Market Gains: Key Facts (abre em uma nova aba)

  Yahoo Finance UK · 1 de out. de 2026

• Amgen (NASDAQ:AMGN) Scores Late-Stage Immunology Win (abre em uma nova aba)

  Kalkine Media · 1 de out. de 2026

• Walt Disney, Amgen Share Losses Lead Dow's 150-Point Fall (abre em uma nova aba)

  富途牛牛 · 1 de out. de 2026

• What Is The Options Market Telling Us About Eli Lilly Stock? (abre em uma nova aba)

  1 de out. de 2026

• amgen weight loss drug trial update (abre em uma nova aba)

  polskieradio.pl · 1 de out. de 2026

• Lilly vs. Novo: Inside the Milan EASD Showdown and the ETFs Poised to Win (abre em uma nova aba)

  1 de out. de 2026

• Amgen reports Phase 3 results and Amgen stock trades at EUR 371.13 (abre em uma nova aba)

  AD HOC NEWS · 1 de out. de 2026

• 
  2 Profitable Stocks with Exciting Potential and 1 We Find Risky (abre em uma nova aba)

  1 de out. de 2026

• Therapeutic Antibody Market Is Going to Boom |• Roche • AbbVie • Amgen (abre em uma nova aba)

  openPR.com · 1 de out. de 2026

• Is Amgen (AMGN) Undervalued Following Its Phase 3 Sjögren's Disease Trial Update? (abre em uma nova aba)

  Simply Wall Street · 30 de set. de 2026

• Recombinant Proteins Market - Global Strategic Business Report: Sales Hit to $5.8 Billion by 2030 - Benchmark Thermo Fisher Scientific, Merck KGaA, Amgen, Bio-Techne and GenScript Biotech Amid Tariff Disruption (abre em uma nova aba)

  30 de set. de 2026

• Amgen Research Offers Clue to Weight-Loss Drug Paradox (abre em uma nova aba)

  Bloomberg.com · 30 de set. de 2026

• Amgen Readies Daxdilimab For Phase III In Discoid Lupus After Mid-Stage Trial (abre em uma nova aba)

  insights.citeline.com · 30 de set. de 2026

• Amgen reveals 6-point drop in lupus severity behind phase 2 win for Horizon antibody (abre em uma nova aba)

  Fierce Biotech · 30 de set. de 2026

• Amgen Inc. stock outperforms competitors on strong trading day (abre em uma nova aba)

  marketwatch.com · 29 de set. de 2026

• Is Eli Lilly Stock a Good Fit For Your Portfolio Risk? (abre em uma nova aba)

  29 de set. de 2026

• BMS’s Opdivo patent suit against Amgen adds to eventful 2026 for biosimilar spats (abre em uma nova aba)

  IAM Media · 29 de set. de 2026

• Management Raised the Bar For Eli Lilly Stock; Does The Chart Agree? (abre em uma nova aba)

  29 de set. de 2026

• Why Amgen’s 6% Dividend Raise Masks a Tougher Road Ahead (abre em uma nova aba)

  29 de set. de 2026

• Amgen-Produced Systemic Treatment for Sjogrens Disease Yields Positive Results (abre em uma nova aba)

  Labroots · 29 de set. de 2026

• Keyron Appoints Former FDA Medical Device Center Director David Feigal as Board Chair (abre em uma nova aba)

  29 de set. de 2026

• Amgen (AMGN) Has a New Growth Opportunity. But How Much Is It Really Worth? (abre em uma nova aba)

  29 de set. de 2026